Literature DB >> 26136937

Effect of erythropoietin on the expression of dynamin-related protein-1 in rat renal interstitial fibrosis.

Xian-Feng Zhao1, Yan-Hong Liu2, Zi-Ming Han3, Y U Xu1.   

Abstract

This study aimed to observe the expression of dynamin-related protein-1 (Drp-1) in the renal interstitium in a rat model of renal interstitial fibrosis induced by unilateral ureteral obstruction (UUO). In addition, the renoprotective effect of erythropoietin in this model was investigated. A total of 81 rats were randomly assigned to sham surgery, UUO model and treatment groups. Following surgery, the rats in the treatment group were subcutaneously administered erythropoietin at a dose of 3,000 IU/kg once a week until the time of sacrifice. Rats in the sham surgery and UUO model groups were administered an identical volume of normal saline. In each group, nine rats were chosen randomly for sacrifice on days 7, 14 and 21 after surgery for histological examination of renal tissue. Renal tissue specimens were examined by hematoxylin and eosin and Masson's trichrome staining. Immunohistochemical analysis was performed to determine the expression of Drp-1 in the renal interstitium. Renal function damage, as evaluated by the measurement of serum creatinine (Cr) and blood urea nitrogen (BUN) levels, was less severe in the treatment group compared with that in the model group at day 21 (P<0.01). Compared with the UUO model group, the renal interstitial injury score and fibrotic area of the treatment group were decreased markedly at the three time points (P<0.05). The expression level of Drp-1 in the treatment group was decreased markedly at the three time points compared with that in the model group (P<0.05). In conclusion, the expression of Drp-1 is increased in rat renal interstitial fibrosis, and erythropoietin may alleviate the degree of renal interstitial fibrosis by downregulating the expression of Drp-1.

Entities:  

Keywords:  dynamin-related protein-1; erythropoietin; renal interstitial fibrosis

Year:  2015        PMID: 26136937      PMCID: PMC4473659          DOI: 10.3892/etm.2015.2419

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  31 in total

1.  Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis.

Authors:  Craig Brooks; Sung-Gyu Cho; Cong-Yi Wang; Tianxin Yang; Zheng Dong
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-15       Impact factor: 4.249

2.  TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.

Authors:  María Concepción Izquierdo; Ana B Sanz; Sergio Mezzano; Julia Blanco; Susana Carrasco; María Dolores Sanchez-Niño; Alberto Benito-Martín; Marta Ruiz-Ortega; Jesús Egido; Alberto Ortiz
Journal:  Kidney Int       Date:  2012-01-25       Impact factor: 10.612

Review 3.  Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.

Authors:  M Brines; A Cerami
Journal:  Kidney Int       Date:  2006-05-31       Impact factor: 10.612

4.  TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast.

Authors:  Alvaro C Ucero; Alberto Benito-Martin; Isabel Fuentes-Calvo; Beatriz Santamaria; Julia Blanco; Jose M Lopez-Novoa; Marta Ruiz-Ortega; Jesus Egido; Linda C Burkly; Carlos Martinez-Salgado; Alberto Ortiz
Journal:  Biochim Biophys Acta       Date:  2013-06-06

5.  Antifibrotic properties of relaxin: in vivo mechanism of action in experimental renal tubulointerstitial fibrosis.

Authors:  Tim D Hewitson; Wen Yang Ho; Chrishan S Samuel
Journal:  Endocrinology       Date:  2010-09-08       Impact factor: 4.736

Review 6.  Erythropoietin as an antiapoptotic, tissue-protective cytokine.

Authors:  P Ghezzi; M Brines
Journal:  Cell Death Differ       Date:  2004-07       Impact factor: 15.828

Review 7.  Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction.

Authors:  Frank Strutz
Journal:  Clin Transplant       Date:  2009-12       Impact factor: 2.863

Review 8.  Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.

Authors:  Robert L Chevalier; Michael S Forbes; Barbara A Thornhill
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

Review 9.  Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure.

Authors:  Masaomi Nangaku
Journal:  Intern Med       Date:  2004-01       Impact factor: 1.271

10.  Erythropoietin attenuates renal injury in an experimental model of rat unilateral ureteral obstruction via anti-inflammatory and anti-apoptotic effects.

Authors:  Yoon-Kyung Chang; Dae Eun Choi; Ki-Ryang Na; Sang-Ju Lee; Kwang-Sun Suh; Suk Young Kim; Young-Tai Shin; Kang Wook Lee
Journal:  J Urol       Date:  2009-01-20       Impact factor: 7.450

View more
  3 in total

1.  AKT/foxo3a signal pathway mediates the protective mechanism of resveratrol on renal interstitial fibrosis and oxidative stress in rats with unilateral ureteral obstruction.

Authors:  Rongrong Sun; Qu Zheng
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 2.  Advances in Understanding the Effects of Erythropoietin on Renal Fibrosis.

Authors:  Yangyang Zhang; Xiaoyu Zhu; Xiu Huang; Xuejiao Wei; Dan Zhao; Lili Jiang; Xiaoxia Zhao; Yujun Du
Journal:  Front Med (Lausanne)       Date:  2020-02-21

3.  PPAR γ/TLR4/TGF-β1 axis mediates the protection effect of erythropoietin on cyclosporin A-induced chronic nephropathy in rat.

Authors:  Bin Liu; Ping Tan
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.